Axsome Therapeutics, Inc
XNAS:AXSM
149.22
$165.90 - 50.00
$145.00 - 7.00
$147.6
$151.63
$148.08
$148.04
152.94
75.56
487200
492311.7
41383804.17
Chart
TendieTensor AI Analysis
Company
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Fundamentals
816
-31.930000
101.015000
100
BBG00B6G7GL7
BBG00B6G7GM6
49.90M
50.41M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own AXSM. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.